Author:
Kong Ming Chai,Lim Teong Guan,Ng Heng Joo,Chan Yiong Huak,Lee Lai Heng
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference22 articles.
1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375 May 9
2. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
3. Osseby GV, Benatru I, Sochurkova D, Urbinelli R, Megherbi SE, Couvreur G, Moreau T, Wolf J, Giroud M (2004) Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice. Prev Med 38(2):121–128 Feb
4. Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL (2005) Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation. Can J Cardiol 21(3):257–266 Mar
5. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):204S–233S Sep
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献